Tracking the Globalization of Clinical Trials:

“As biopharmaceutical companies begin to take advantage of the numerous benefits associated with holding overseas clinical trials, we are experiencing a dramatic transformation in the pharmaceutical industry landscape. However, among these advantages, translation and localization remain obstacles to a company’s ability to conduct a successful clinical project. Here, we utilize China, Israel, and Poland as examples of a growing international clinical trial market, discuss specific national translation requirements, and examine how LSPs can ease the transition for pharmaceutical companies conducting international trials.”